Cargando…

Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation

Resveratrol (RES), a non-flavonoid polyphenol extracted from a wide variety of plants, exhibits neuroprotective activities against Parkinson's disease (PD). However, undesirable water solubility of RES reduces its oral bioavailability and demonstrates low efficacy in blood and brain, thus limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Sha, Liu, Wei, Zhou, Yile, Mo, Yousheng, Liu, Yao, Chen, Xiaojia, Pan, Huafeng, Yuan, Dongsheng, Wang, Qi, Chen, Tongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486547/
https://www.ncbi.nlm.nih.gov/pubmed/32952674
http://dx.doi.org/10.1016/j.ajps.2019.04.003
_version_ 1783581348870488064
author Xiong, Sha
Liu, Wei
Zhou, Yile
Mo, Yousheng
Liu, Yao
Chen, Xiaojia
Pan, Huafeng
Yuan, Dongsheng
Wang, Qi
Chen, Tongkai
author_facet Xiong, Sha
Liu, Wei
Zhou, Yile
Mo, Yousheng
Liu, Yao
Chen, Xiaojia
Pan, Huafeng
Yuan, Dongsheng
Wang, Qi
Chen, Tongkai
author_sort Xiong, Sha
collection PubMed
description Resveratrol (RES), a non-flavonoid polyphenol extracted from a wide variety of plants, exhibits neuroprotective activities against Parkinson's disease (PD). However, undesirable water solubility of RES reduces its oral bioavailability and demonstrates low efficacy in blood and brain, thus limiting its application. In present study, a nanocrystal formulation of RES (RES-NCs) was developed to enhance its oral bioavailability and delivery into brain for PD treatment. RES-NCs were fabricated with hydroxypropyl methylcellulose (HPMC) stabilizer via antisolvent precipitation approach. The obtained RES-NCs displayed the particle size of 222.54 ± 1.66 nm, the PDI of 0.125 ± 0.035, the zeta potential of −9.41 ± 0.37 mV, and a rapid in vitro dissolution rate. Molecular dynamics simulation of RES and HPMC revealed an interaction energy of −68.09 kJ/mol and a binding energy of −30.98 ± 0.388 kJ/mol, indicating that the spontaneous binding between the two molecules is through van der Waals forces. RES-NCs conferred enhanced cellular uptake as well as improved permeability relative to pure RES. In addition, RES-NCs were able to protect neurons against cytotoxicity induced by MPP(+). Meanwhile, RES-NCs exerted no significant toxic effects on zebrafish embryos and larvae, and did not influence their survival and hatching rates. When orally administered to rats, RES-NCs exhibited more favorable pharmacokinetics than pure RES, with higher plasma and brain concentrations. More importantly, MPTP-induced PD mice showed notable improvements in behavior, attenuated dopamine deficiency, and elevated levels of dopamine and its metabolites after the treatment with RES-NCs. Furthermore, immunoblot analysis revealed that the neuroprotective role of RES-NCs may be at least partially mediated by Akt/Gsk3β signaling pathway. Taken altogether, RES-NCs can serve as a potential treatment modality for PD, offering means of improving RES oral bioavailability and brain accumulation.
format Online
Article
Text
id pubmed-7486547
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shenyang Pharmaceutical University
record_format MEDLINE/PubMed
spelling pubmed-74865472020-09-18 Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation Xiong, Sha Liu, Wei Zhou, Yile Mo, Yousheng Liu, Yao Chen, Xiaojia Pan, Huafeng Yuan, Dongsheng Wang, Qi Chen, Tongkai Asian J Pharm Sci Original Research Paper Resveratrol (RES), a non-flavonoid polyphenol extracted from a wide variety of plants, exhibits neuroprotective activities against Parkinson's disease (PD). However, undesirable water solubility of RES reduces its oral bioavailability and demonstrates low efficacy in blood and brain, thus limiting its application. In present study, a nanocrystal formulation of RES (RES-NCs) was developed to enhance its oral bioavailability and delivery into brain for PD treatment. RES-NCs were fabricated with hydroxypropyl methylcellulose (HPMC) stabilizer via antisolvent precipitation approach. The obtained RES-NCs displayed the particle size of 222.54 ± 1.66 nm, the PDI of 0.125 ± 0.035, the zeta potential of −9.41 ± 0.37 mV, and a rapid in vitro dissolution rate. Molecular dynamics simulation of RES and HPMC revealed an interaction energy of −68.09 kJ/mol and a binding energy of −30.98 ± 0.388 kJ/mol, indicating that the spontaneous binding between the two molecules is through van der Waals forces. RES-NCs conferred enhanced cellular uptake as well as improved permeability relative to pure RES. In addition, RES-NCs were able to protect neurons against cytotoxicity induced by MPP(+). Meanwhile, RES-NCs exerted no significant toxic effects on zebrafish embryos and larvae, and did not influence their survival and hatching rates. When orally administered to rats, RES-NCs exhibited more favorable pharmacokinetics than pure RES, with higher plasma and brain concentrations. More importantly, MPTP-induced PD mice showed notable improvements in behavior, attenuated dopamine deficiency, and elevated levels of dopamine and its metabolites after the treatment with RES-NCs. Furthermore, immunoblot analysis revealed that the neuroprotective role of RES-NCs may be at least partially mediated by Akt/Gsk3β signaling pathway. Taken altogether, RES-NCs can serve as a potential treatment modality for PD, offering means of improving RES oral bioavailability and brain accumulation. Shenyang Pharmaceutical University 2020-07 2019-05-24 /pmc/articles/PMC7486547/ /pubmed/32952674 http://dx.doi.org/10.1016/j.ajps.2019.04.003 Text en © 2019 Shenyang Pharmaceutical University. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Paper
Xiong, Sha
Liu, Wei
Zhou, Yile
Mo, Yousheng
Liu, Yao
Chen, Xiaojia
Pan, Huafeng
Yuan, Dongsheng
Wang, Qi
Chen, Tongkai
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title_full Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title_fullStr Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title_full_unstemmed Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title_short Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
title_sort enhancement of oral bioavailability and anti-parkinsonian efficacy of resveratrol through a nanocrystal formulation
topic Original Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486547/
https://www.ncbi.nlm.nih.gov/pubmed/32952674
http://dx.doi.org/10.1016/j.ajps.2019.04.003
work_keys_str_mv AT xiongsha enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT liuwei enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT zhouyile enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT moyousheng enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT liuyao enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT chenxiaojia enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT panhuafeng enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT yuandongsheng enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT wangqi enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation
AT chentongkai enhancementoforalbioavailabilityandantiparkinsonianefficacyofresveratrolthroughananocrystalformulation